CY1113372T1 - Μεθοδος για την κατασκευη φαρμακευτικου σκευασματος ως "παραγοντας μεταφορας" - Google Patents
Μεθοδος για την κατασκευη φαρμακευτικου σκευασματος ως "παραγοντας μεταφορας"Info
- Publication number
- CY1113372T1 CY1113372T1 CY20121100487T CY121100487T CY1113372T1 CY 1113372 T1 CY1113372 T1 CY 1113372T1 CY 20121100487 T CY20121100487 T CY 20121100487T CY 121100487 T CY121100487 T CY 121100487T CY 1113372 T1 CY1113372 T1 CY 1113372T1
- Authority
- CY
- Cyprus
- Prior art keywords
- preparation
- transport factor
- construction
- lyophilization
- medicinal packaging
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 238000010276 construction Methods 0.000 title 1
- 238000004806 packaging method and process Methods 0.000 title 1
- 238000002360 preparation method Methods 0.000 abstract 4
- 239000003814 drug Substances 0.000 abstract 2
- 238000004108 freeze drying Methods 0.000 abstract 2
- 230000001225 therapeutic effect Effects 0.000 abstract 2
- 238000009833 condensation Methods 0.000 abstract 1
- 230000005494 condensation Effects 0.000 abstract 1
- 238000004090 dissolution Methods 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 210000000987 immune system Anatomy 0.000 abstract 1
- 230000002779 inactivation Effects 0.000 abstract 1
- 210000000265 leukocyte Anatomy 0.000 abstract 1
- 229940126601 medicinal product Drugs 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- 230000001954 sterilising effect Effects 0.000 abstract 1
- 238000004659 sterilization and disinfection Methods 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
- 238000000108 ultra-filtration Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/15—Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Τρόπος προφύλαξης του φαρμακευτικού σκευάσματος ως "παράγοντα μεταφοράς", παρασκευής και κλινικής εφαρμογής του. Η παρασκευή περιλαμβάνει τα εξής στάδια: τεχνικές προϋποθέσεις παρασκευής αιωρήματος λευκοκυττάρων, διάλυση ή υπερδιήθηση αυτού, συμπύκνωση μέσω λυοφιλοποίησης, παρασκευή πρώτης ύλης φαρμάκου σε διάλυμα, διήθηση αποστείρωσης, θερμική απενεργοποίηση και τελική λυοφιλοποίηση. Η παρούσα μέθοδος διασφαλίζει την πρότυπη παρασκευή σταθερού στείρου φαρμακευτικού σκευάσματος για κλινική χρήση με ενδεδειγμένη δοσολογία για σκοπούς θεραπείας. Η θεραπευτική δράση του παράγοντα μεταφοράς σχετίζεται κυρίως με τη ρύθμιση του ανοσοποιητικού συστήματος του αποδέκτη.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CZ20060377A CZ299296B6 (cs) | 2006-06-13 | 2006-06-13 | Lécivo transfer faktor - zpusob výroby a použití |
EP07721839A EP2037949B1 (en) | 2006-06-13 | 2007-06-12 | A method of manufacturing a transfer factor medicament |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1113372T1 true CY1113372T1 (el) | 2016-06-22 |
Family
ID=38220655
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20121100487T CY1113372T1 (el) | 2006-06-13 | 2012-05-29 | Μεθοδος για την κατασκευη φαρμακευτικου σκευασματος ως "παραγοντας μεταφορας" |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP2037949B1 (el) |
AT (1) | ATE547111T1 (el) |
CY (1) | CY1113372T1 (el) |
CZ (1) | CZ299296B6 (el) |
DK (1) | DK2037949T3 (el) |
ES (1) | ES2383351T3 (el) |
PL (1) | PL2037949T3 (el) |
SI (1) | SI2037949T1 (el) |
WO (1) | WO2007143957A2 (el) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX338863B (es) * | 2011-12-16 | 2016-05-01 | Inst Politecnico Nacional | Metodo de obtencion de extracto dializable de leucocitos. |
CZ2020342A3 (cs) * | 2020-06-12 | 2021-12-22 | AUMED, a.s. | Způsob přípravy léčiva transfer faktor, léčivo transfer faktor, metodika testování biologické účinnosti, léková forma a její použití |
CN113304172A (zh) * | 2021-06-10 | 2021-08-27 | 哈尔滨圣泰生物制药有限公司 | 一种转移因子口服溶液的制备方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3991182A (en) * | 1971-10-19 | 1976-11-09 | The Regents Of The University Of California | Transfer factor |
WO1980000790A1 (en) * | 1978-10-25 | 1980-05-01 | Benzon As Alfred | Transfer factor and method for producing same |
US4468379A (en) * | 1982-05-06 | 1984-08-28 | Endeavor Corp. | Leukocyte extracts for affecting the immune system |
ZA835244B (en) * | 1982-07-20 | 1985-02-27 | Bio Com Inc | Transfer factor for use in treating viral infections |
DE3244607A1 (de) * | 1982-12-02 | 1984-06-07 | Bezirksblutspendezentrale Plauen, DDR 9900 Plauen | Verfahren zur herstellung von humanen transfer-faktor-praeparaten |
ATE158184T1 (de) * | 1990-07-02 | 1997-10-15 | Nat Jewish Ct Immun & Respirat | Herstellung und verwendung von transfer-faktor |
CN1093907A (zh) * | 1993-12-19 | 1994-10-26 | 陕西省生物制品研究所 | 口服转移因子 |
MXPA02002171A (es) * | 2002-02-28 | 2002-12-09 | Antonio Calzada Nova Luis | Extracto de leucocitos dializado en la elaboracion de un farmaco para el tratamiento de enfermedades infecciosas en animales. |
CN100413534C (zh) * | 2003-11-03 | 2008-08-27 | 西北农林科技大学 | 一种治疗奶牛临床乳房炎的生物性免疫制剂及其制作方法 |
CN1654477A (zh) * | 2004-02-13 | 2005-08-17 | 北京世纪昭宝转移因子研究中心 | 制备转移因子工艺方法-加热法 |
-
2006
- 2006-06-13 CZ CZ20060377A patent/CZ299296B6/cs not_active IP Right Cessation
-
2007
- 2007-06-12 EP EP07721839A patent/EP2037949B1/en active Active
- 2007-06-12 DK DK07721839.4T patent/DK2037949T3/da active
- 2007-06-12 SI SI200730919T patent/SI2037949T1/sl unknown
- 2007-06-12 AT AT07721839T patent/ATE547111T1/de active
- 2007-06-12 PL PL07721839T patent/PL2037949T3/pl unknown
- 2007-06-12 ES ES07721839T patent/ES2383351T3/es active Active
- 2007-06-12 WO PCT/CZ2007/000050 patent/WO2007143957A2/en active Application Filing
-
2012
- 2012-05-29 CY CY20121100487T patent/CY1113372T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
PL2037949T3 (pl) | 2012-10-31 |
EP2037949A2 (en) | 2009-03-25 |
WO2007143957A2 (en) | 2007-12-21 |
WO2007143957A3 (en) | 2008-05-08 |
DK2037949T3 (da) | 2012-06-18 |
SI2037949T1 (sl) | 2012-07-31 |
EP2037949B1 (en) | 2012-02-29 |
WO2007143957B1 (en) | 2008-06-26 |
ATE547111T1 (de) | 2012-03-15 |
ES2383351T3 (es) | 2012-06-20 |
CZ2006377A3 (cs) | 2007-07-04 |
CZ299296B6 (cs) | 2008-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Paradowska-Stolarz et al. | Natural polymers for the maintenance of oral health: Review of recent advances and perspectives | |
CY1122291T1 (el) | Αναστολeις ιικου αναδιπλασιασμου | |
HUP0400882A2 (hu) | Onkolitikus vírusterápia | |
MX2015004290A (es) | Formulacion que contiene virus y uso de la misma. | |
MX2011006077A (es) | Vacuna de peptido ch3 de ige. | |
MX2011013150A (es) | Composicion farmaceutica para uso en oftalmologia medica y veterinaria. | |
MD4430C1 (ro) | Compoziţii şi metode de tratament al hepatitei virale C | |
EA200702522A1 (ru) | Система доставки лекарств в полость рта и способы ее применения | |
CY1105408T1 (el) | Χρησιμοποιηση στελεχων του ιου parapox ovis για την παρασκευη αντιικων φαρμακων και φαρμακων κατα του καρκινου | |
EP2942061A3 (en) | Ige ch3 peptide vaccine | |
MX349090B (es) | Dispositivo separador modular para el tratamiento de infecciones de la prótesis de las extremidades humanas. | |
RU2013148779A (ru) | Лечение инфекции вируса гепатита в по отдельности или в комбинации с вирусом гепатита дельта и родственных заболеваний печени | |
CY1113372T1 (el) | Μεθοδος για την κατασκευη φαρμακευτικου σκευασματος ως "παραγοντας μεταφορας" | |
BRPI0413129A (pt) | medicamentos para inalação compreendendo betamiméticos e anticolinérgico | |
NZ703919A (en) | Treatment of cancer with elevated dosages of soluble fgfr1 fusion proteins | |
CY1115394T1 (el) | Φαρμακευτικη συνθεση του ιβuρrοfeν για ενεση | |
AR041891A1 (es) | Empleo de resveratrol para la preparacion de un medicamento util para el tratamiento de infecciones causadas por el virus de la influenza | |
BR0116653A (pt) | Medicamento contendo uma poliamina como substância ativa | |
CY1113230T1 (el) | 1-φαινυλ-2-ετεροαρυλ-υποκατεστημενα παραγωγα βενζιμιδαζολιου, η χρηση αυτων για την παρασκευη φαρμακων που χρησιμοποιουνται στη θεραπεια ανοσολογικων ασθενειων | |
RU2013129824A (ru) | Новое лечение инфекции вируса гепатита с | |
Šetrajčić et al. | Core-shell nanomodels for biomedical applications | |
ATE408670T1 (de) | Autologous selbst-toleranz induzierende zellen monozytären ursprungs und ihren verwendung in artzneimitteln | |
BR112014005221A2 (pt) | uso de materiais de fibra oca modificada para a remoção de exotoxinas produzidas por escherichia coli a partir de liquidos, de preferência a partir de sangue e de plasma, bem como seu uso para o tratamento de doenças concomitantes | |
BRPI0803473B8 (pt) | nanopartícula de albumina transportadora de fármacos para terapia fotodinâmica e seu processo de preparo | |
Kalivas et al. | Reply to: N-Acetylcysteine in Treatment of Substance Use Disorders |